PR Newswire Clinical TrialsOriginal article
New Real-World Data Show penKid Adding Decision Support for Kidney Replacement Therapy in Critical Care
Data ReadoutpositivepenKidPositive
AI Analysis
Summary
Real-world data from a prospective study of 1,436 critically ill ICU patients demonstrates that penKid (proenkephalin A 119–159) provides clinically relevant information for managing acute kidney injury and kidney replacement therapy in critical care settings.
Clinical Trial Data
Primary Endpoint
Met
Patients
1,436
Outcome Details
Real-world study of 1,436 critically ill ICU patients showed penKid provided clinically relevant information across AKI severity and during kidney replacement therapy management
Importance:6/10
Sentiment:
0.70
real-world datacritical carekidney diseasedecision supportICU patientsAKI
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on August 27, 2026 8:21 AM